|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
PT728214E
(pt)
|
1993-11-09 |
2004-11-30 |
Ohio Med College |
Linhas celulares estaveis capazes de expressar o gene de replicacao do virus adeno-associado
|
|
PT733103E
(pt)
|
1993-11-09 |
2004-07-30 |
Targeted Genetics Corp |
Criacao de elevados titulos de vectores de aav recombinantes
|
|
US5658785A
(en)
|
1994-06-06 |
1997-08-19 |
Children's Hospital, Inc. |
Adeno-associated virus materials and methods
|
|
US5856152A
(en)
|
1994-10-28 |
1999-01-05 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV vector and methods of use therefor
|
|
AU707866B2
(en)
|
1994-12-06 |
1999-07-22 |
Targeted Genetics Corporation |
Packaging cell lines for generation of high titers of recombinant AAV vectors
|
|
FR2737730B1
(fr)
|
1995-08-10 |
1997-09-05 |
Pasteur Merieux Serums Vacc |
Procede de purification de virus par chromatographie
|
|
AU722196B2
(en)
|
1995-08-30 |
2000-07-27 |
Genzyme Corporation |
Chromatographic purification of adenovirus and AAV
|
|
EP1983057A3
(en)
|
1995-09-08 |
2009-01-07 |
Genzyme Corporation |
Improved AAV vectors for gene therapy
|
|
US5910434A
(en)
|
1995-12-15 |
1999-06-08 |
Systemix, Inc. |
Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
|
|
EP0932418B1
(en)
|
1996-09-06 |
2007-12-05 |
The Trustees Of The University Of Pennsylvania |
Method for recombinant adeno-associated virus-directed gene therapy
|
|
JP2001514845A
(ja)
|
1997-09-05 |
2001-09-18 |
ターゲティッド ジェネティクス コーポレイション |
組換えａａｖベクターの高力価ヘルパーなし調製物を生成するための方法
|
|
US6566118B1
(en)
|
1997-09-05 |
2003-05-20 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
US6258595B1
(en)
|
1999-03-18 |
2001-07-10 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
CA2406743A1
(en)
|
2000-04-28 |
2001-11-08 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
|
|
USH2191H1
(en)
*
|
2000-10-24 |
2007-06-05 |
Snp Consortium |
Identification and mapping of single nucleotide polymorphisms in the human genome
|
|
AU2002248297A1
(en)
|
2001-01-05 |
2002-07-16 |
Children's Hospital, Inc. |
Aav2 vectors and methods
|
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
|
US7250496B2
(en)
*
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
|
WO2012024535A2
(en)
*
|
2010-08-18 |
2012-02-23 |
Fred Hutchinson Cancer Research Center |
Methods for determining the presence or risk of developing facioscapulohumeral dystrophy (fshd)
|
|
WO2012109570A1
(en)
*
|
2011-02-10 |
2012-08-16 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
|
AU2012286994B2
(en)
|
2011-07-25 |
2017-08-10 |
Nationwide Children's Hospital, Inc. |
Recombinant virus products and methods for inhibition of expression of DUX4
|
|
DE102012007232B4
(de)
|
2012-04-07 |
2014-03-13 |
Susanne Weller |
Verfahren zur Herstellung von rotierenden elektrischen Maschinen
|
|
JP2015092462A
(ja)
|
2013-09-30 |
2015-05-14 |
Tdk株式会社 |
正極及びそれを用いたリチウムイオン二次電池
|
|
JP6202701B2
(ja)
|
2014-03-21 |
2017-09-27 |
株式会社日立国際電気 |
基板処理装置、半導体装置の製造方法及びプログラム
|
|
JP6197169B2
(ja)
|
2014-09-29 |
2017-09-20 |
東芝メモリ株式会社 |
半導体装置の製造方法
|
|
US10538763B2
(en)
*
|
2015-01-16 |
2020-01-21 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulation of DUX4
|
|
CN109153980B
(zh)
*
|
2015-10-22 |
2023-04-14 |
布罗德研究所有限公司 |
Vi-b型crispr酶和系统
|
|
US10828377B2
(en)
*
|
2015-10-26 |
2020-11-10 |
The University Of Tokyo |
Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and agent for treatment and/or prevention of leukemia
|
|
FI3373980T3
(fi)
*
|
2015-11-12 |
2025-07-10 |
The Res Institute At Nationwide Childrens Hospital |
Menetelmiä lihasdystrofian hoitamiseksi
|
|
AU2017222653B2
(en)
*
|
2016-02-26 |
2023-06-01 |
Research Institute At Nationwide Children's Hospital |
Recombinant virus products and methods for inducing DUX4 exon skipping
|
|
BR112018070249A2
(pt)
*
|
2016-04-02 |
2019-01-29 |
Research Institute At Nationwide Children's Hospital |
sistema promotor de u6 modificada para expressão específica de tecido
|
|
CA3074723A1
(en)
*
|
2016-09-23 |
2018-03-29 |
University Of Massachusetts |
Silencing of dux4 by recombinant gene editing complexes
|
|
JP7231226B2
(ja)
*
|
2016-11-07 |
2023-03-01 |
ユニバーシティ オブ マサチューセッツ |
顔面肩甲上腕型筋ジストロフィーのための治療標的
|
|
AU2018234825B2
(en)
|
2017-03-15 |
2020-12-17 |
Massachusetts Institute Of Technology |
Novel CAS13B orthologues CRISPR enzymes and systems
|
|
AU2018251801B2
(en)
*
|
2017-04-12 |
2024-11-07 |
Massachusetts Institute Of Technology |
Novel type VI CRISPR orthologs and systems
|
|
EP3640329A1
(en)
*
|
2018-10-18 |
2020-04-22 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Gene editing based cancer treatment
|
|
IL303230A
(en)
*
|
2020-11-30 |
2023-07-01 |
Res Inst Nationwide Childrens Hospital |
Compositions and methods for treating facioscapulohumeral muscular dystrophy (fshd)
|
|
WO2022169922A1
(en)
*
|
2021-02-03 |
2022-08-11 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for treating disease associated with dux4 overexpression
|